โœ“ FDA Approved โญ Newest GLP-1 ยท Eli Lilly

Foundayo

Orforglipron ยท Approved April 2026

Foundayo (orforglipron) is the first GLP-1 weight loss pill with no food or water restrictions. Take it anytime, with or without a meal. A major breakthrough for the roughly 40% of people who struggle with Oral Wegovy's strict dosing rules.

๐Ÿ’Š
At a Glance

Everything You Need to Know

Avg. Weight Loss
9-15%
Of starting body weight
Form & Schedule
Daily Pill
Once per day, any time
Food Restriction
None
Take with or without food
Active Ingredient
Orforglipron
Non-peptide GLP-1 agonist
Manufacturer
Eli Lilly
Same maker as Zepbound
FDA Status
โœ… Approved
Approved April 2026
Plain English

What Exactly Is Foundayo?

A once daily pill that curbs hunger. No meal timing required.Foundayo is a once-daily pill that helps your body feel full faster and reduces hunger without requiring you to time it around meals.

Most GLP-1 pills on the market are made from peptides, molecules that break down when they touch food. That's why Oral Wegovy requires an empty stomach, plain water, and a 30-minute wait. Foundayo (orforglipron) is different. It's made from a small molecule that doesn't interact with food at all, so you can take it whenever it fits your routine: morning, afternoon, with breakfast, after dinner, it doesn't matter.

The result? The same proven GLP-1 weight loss mechanism, with dramatically simpler daily use.

The Science, Simply

How Foundayo Works

It targets your brain and gut, not your willpower.Foundayo works on your brain and gut, not your willpower.

1

Activates GLP-1 Receptors

Orforglipron binds to GLP-1 receptors in your brain and gut the same receptors that your body naturally activates when you eat a satisfying meal. This signals "I'm full" even before you've overeaten.

2

Slows Digestion

Food moves more slowly through your stomach, keeping you feeling fuller for longer after each meal. You naturally eat less not because you're forcing yourself, but because the hunger simply isn't there.

3

Reduces Food Cravings

GLP-1 receptors in the brain's reward center reduce the appeal of high-calorie foods. Many users report that food "noise" the constant mental preoccupation with eating drops significantly within weeks.

Clinical Trial Data

What the Trials Showed

From the ATTAIN trials: thousands of adults, 36 plus weeks of data.Foundayo's approval was based on the ATTAIN clinical trial program, which studied thousands of adults over 36 weeks and beyond.

15%
Average Body Weight Lost
At highest dose over 36 weeks
9 in 10
Participants Lost Weight
vs. 1 in 3 on placebo
25 lbs
Average Pounds Lost
For a 170 lb person
โ„น๏ธ Individual results vary. Trial participants also followed a reduced-calorie diet and increased physical activity. Weight loss is typically gradual, with most results seen between weeks 12-36.

"Most of my patients aren't thinking about GLP-1 mechanisms when they're deciding whether to stay on a medication. They're thinking about whether it fits into their morning. Foundayo is the first one where I don't have to have that conversation."

Dr. Quoc N. Dang, DO

Dr. Quoc N. Dang, DO

Bariatric Surgeon ยท Obesity Medicine

Eligibility

Is Foundayo Right for You?

Prescription only. Here's who it fits and who should look elsewhere.Foundayo requires a prescription. Here's who it's typically prescribed for and who should consider other options.

โœ… Good Candidates

  • BMI of 30 or higher (clinically obese)
  • BMI of 27+ with a weight-related condition (diabetes, high blood pressure, high cholesterol)
  • Adults who struggled with Oral Wegovy's empty-stomach requirement
  • People who prefer a pill over weekly injections
  • Those looking for a newer, non-peptide GLP-1 option

โš ๏ธ May Not Be Right If...

  • You have a personal or family history of thyroid cancer (MTC)
  • You have Multiple Endocrine Neoplasia syndrome type 2
  • You're pregnant, planning to become pregnant, or breastfeeding
  • You have a history of pancreatitis
  • You're already on another GLP-1 medication

โš•๏ธ Always consult your doctor before starting any weight loss medication.

What to Expect

Side Effects

Mostly mild and typically improve within 4 to 8 weeks.Most side effects are mild and improve as your body adjusts, typically within the first 4 to 8 weeks. Starting on a low dose helps reduce them significantly.

Common Side Effects

Usually mild ยท Often improve over time
  • Nausea30%
  • Diarrhea18%
  • Vomiting12%
  • Constipation10%
  • Decreased appetite15%
  • Stomach discomfort9%

Serious (Rare) Side Effects

Uncommon ยท Contact your doctor immediately
  • Severe abdominal pain (possible pancreatitis)
  • Rapid heart rate
  • Kidney problems (from dehydration)
  • Gallbladder disease
  • Severe allergic reaction
Pricing & Access

What Does Foundayo Cost?

What you pay depends on insurance and savings program eligibility.Cost varies significantly depending on your insurance and whether you qualify for Eli Lilly's savings programs.

Self-Pay (No Insurance)

$149-$299/mo
Through LillyDirect with free home delivery. Price depends on your prescribed dose.

With Commercial Insurance

As low as $25/mo
Eli Lilly's savings program for eligible commercially insured patients.

Medicare Part D

$50/mo
Available to eligible Medicare patients starting July 2026.
๐Ÿ’ก Tip: Foundayo is available directly through LillyDirect with free home delivery. Self-pay starts at $149/month. Commercially insured patients may pay as little as $25/month with Lilly's savings card.
Side by Side

Foundayo vs. Other Options

Foundayo vs. the other leading weight loss medications.How does Foundayo stack up against the other leading weight loss medications?

Medication Avg. Weight Loss Form Food Restriction Approved For
๐Ÿ’ŠFoundayo You're here 9-15% Daily Pill None โœ“ Weight Loss
๐Ÿ’ŠOral Wegovy 15% Daily Pill Empty stomach Weight Loss
๐Ÿ’‰Zepbound 21% Weekly Injection None โœ“ Weight Loss
๐Ÿ’‰Wegovy 15% Weekly Injection None โœ“ Weight Loss
Common Questions

Frequently Asked Questions

Yes this is Foundayo's biggest advantage over Oral Wegovy. Because orforglipron is a small molecule (not a peptide), it doesn't bind to food in your stomach. You can take it any time of day, with a full meal, a snack, or nothing at all.
Both are daily pills that work on GLP-1 receptors, but their chemistry is very different. Oral Wegovy (semaglutide) is a peptide that degrades when it touches food, requiring strict empty-stomach dosing. Foundayo (orforglipron) is a small molecule that isn't affected by food, making it far more flexible. Oral Wegovy shows slightly higher average weight loss in trials (15% vs 9-15%), but adherence is often lower due to the dosing restrictions.
Most people notice reduced appetite within the first 1-2 weeks. Meaningful weight loss typically becomes visible between weeks 4-8, with the most significant results occurring between weeks 12-36. Foundayo is a long-term treatment consistent daily use paired with healthier eating habits produces the best outcomes.
This is a real consideration with all GLP-1 medications. Clinical data shows that most people regain a significant portion of lost weight within 12 months of stopping. Many doctors view these medications as long-term or lifelong treatments, similar to how blood pressure medication is used. Discuss a long-term plan with your doctor before starting.
Foundayo can affect the absorption and metabolism of other medications because it slows gastric emptying. One thing to flag, it may reduce the effectiveness of oral contraceptives your doctor may recommend using a backup method of contraception for a period after starting. Always give your doctor a full list of medications and supplements you're taking.
Dr. Quoc N. Dang, DO
Medically Reviewed by
Dr. Quoc N. Dang, DO
Bariatric Surgeon